Pear Therapeutics

FDA to expedite clearance for Pear's digital therapeutic for opioid addiction
By Jonah Comstock | 02:46 pm | October 18, 2017
Apple, Fitbit, Samsung, and Verily among FDA's picks for precertification pilot
By Jonah Comstock | 02:33 pm | September 26, 2017
Pear Therapeutics gets de novo FDA clearance for reSET, a digital therapeutic for substance abuse
By Jonah Comstock | 04:33 pm | September 14, 2017
In-depth: The path to market for digital tools for mental health and neurological conditions
By Heather Mack | 05:10 pm | March 17, 2017
Pharma's investment in digital health increasing, but still in early stages
By Jonah Comstock | 02:47 pm | September 15, 2016
Study shows high engagement with digital therapy for schizophrenia spectrum disorders
By Heather Mack | 04:14 pm | August 25, 2016
Digital health funding in February reached $197 million
By Aditi Pai | 09:52 am | March 03, 2016
Pear Therapeutics raises $20M for digital combination interventions, starting with substance use disorders
By Aditi Pai | 02:37 pm | February 03, 2016
Pear Therapeutics raises money for drug-software combo products
By Aditi Pai | 11:03 am | March 23, 2015